Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 2007

View Archived Issues

Modest weight loss seen with pharmacotherapy for obesity/overweight

Gabapentin shows potential for treatment and prevention of high-altitude headache

Brivaracetam well tolerated and safe in patients with partial-onset seizures

Carisbamate reduces frequency of partial-onset seizures

MediGene and Celltrion sign agreement for anti-L1 monoclonal antibody for cancer

Inspire initiates phase III clinical trial of epinastine nasal spray for seasonal allergic rhinitis

Mitsubishi Tanabe reports first half ended September 30, 2007

Plethora reports positive preliminary results from phase II study of PSD-503

Nymox reports positive results from clinical study of NX-1207

Eurand completes gastrointestinal bioavailability study of Zentase for chronic pancreatitis

Valeant initiates phase IIa trial of retigabine for postherpetic neuralgia

LifeCycle initiates phase I clinical trial of sirolimus for organ rejection after transplantation

Regeneron and sanofi-aventis enter collaboration for fully human therapeutic antibodies

AnGes signs licensing agreement with Meyer for NF-kappaB decoy in the U.S. and Europe

Roche accepts FDA recommendation to add stronger warning label to Tamiflu

Celsion reports positive results from animal and stability studies of liposomal docetaxel

ChemGenex receives shareholder approval to demerge Verva

Cosmo reports positive results from phase II trial of Rifamycin SV MMX for diarrhea

Recent Novartis and Almirall patents impart novel therapeutic agents for respiratory disorders

New analgesic agents described in recent patent literature

FDA advisory panel recommends approval of Promus/Xience V

FDA issues approvable letter in response to Mylan's NDA for nebivolol for hypertension

FDA approves Alcon's Triesence for use in eye surgery

Chugai and Roche submit MAA to EMEA for Actemra for severe rheumatoid arthritis

FDA approves Eli Lilly's Cymbalta for major depressive disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...